The pitch behind Capital Group Growth ETF (NYSEARCA:CGGR) is that a veteran team can beat the index by leaning into the same megacap winners it already owns, only more deliberately concentrated, and charge you almost nothing for it. CGGR has grown into one of the larger active growth ETFs on that pitch, anchoring its book with Meta, Tesla, Nvidia, and Broadcom. Whether CGGR is actually paying off depends on which benchmark you hold it against.
What CGGR Is Actually Buying
Capital Group runs CGGR out of the same shop behind American Funds, which means fundamental research, low turnover in the mid-teens, and an expense ratio of 0.39%. That is roughly a fifth of what a typical actively managed fund charges and puts CGGR within striking distance of pure passive growth ETFs. The structural advantage matters: active ETFs historically struggle to justify their fees, but CGGR’s pricing removes the most common objection before the debate over stock selection even begins.
The holdings are doing their job. NVIDIA (NASDAQ:NVDA | NVDA Price Prediction) reported Q1 FY27 revenue of $82 billion, up 85% year over year, with Data Center revenue of $75 billion. CEO Jensen Huang framed the setup bluntly, calling the AI factory buildout “the largest infrastructure expansion in human history.” Meta Platforms (NASDAQ:META) delivered Q1 2026 revenue of $56 billion, up 33% year over year, though the $10.44 EPS beat consensus of $6.66 largely because of an $8 billion tax benefit.
Broadcom (NASDAQ:AVGO) is up roughly 29% over the trailing year, with AI semiconductor revenue tracking toward CEO Hock Tan’s stated $100B target by 2027. Even Tesla (NASDAQ:TSLA), the volatile one, is about 19% higher over the past 12 months, helped by an expansion in auto gross margin to 21.1% and FSD subscriptions crossing 1.28 million. So the underlying names are working. Holdings, though, are not the same as fund returns, and that gap is where the CGGR story gets complicated.
How The Fund Actually Performed
CGGR returned roughly 11% over the trailing twelve months. The S&P 500 returned about 21% over the same window, and the Nasdaq-100 returned 25%. Vanguard’s passive growth ETF delivered about 17%, Schwab’s competing product returned about 18%, and the iShares Russell 1000 Growth vehicle came in at around 13%, essentially tied with CGGR. The dispersion is not enormous in absolute terms, but for an actively managed fund selling itself on stock-picking edge, trailing three of four passive peers is a meaningful result.
An investor who bought CGGR twelve months ago for its Magnificent Seven concentration got a fund that trailed the plain S&P 500 meaningfully and lagged every mainstream passive growth alternative except the Russell 1000 Growth tracker. Year to date, the pattern holds, with CGGR up under 4% against roughly 10% for SPY and nearly 15% for QQQ. The short-term scoreboard is not kind to the active thesis.
The multi-year picture is kinder. Since early 2022, CGGR has returned roughly 90%, competitive with VUG’s 84% and SCHG’s 91%, though still short of QQQ’s 97%. Over a full cycle that spans the 2022 drawdown and the subsequent AI-led recovery, the fund is roughly earning its keep. Over the past year, it has not been, and investors evaluating a purchase today have to decide which window matters more.
What The Concentration Costs
Active management in a top-heavy market is a hard job. Any underweight in the largest names, even a small one, costs real return when those names lead, and a 0.39% fee is generous by active standards but still meaningfully more than what the leading passive growth funds charge for essentially the same top-five exposure. The math is unforgiving: when the index’s top holdings are also the year’s best performers, the active manager needs conviction bets outside those names to add value, and CGGR’s low turnover suggests those bets are not being made aggressively.
Concentration works both ways. If the megacap trade cracks, CGGR cracks with it, and turnover of around 16% suggests the manager will not rotate quickly. Nvidia alone, trading at a P/E of 42x on a $4.8 trillion market cap, represents both the fund’s biggest tailwind and its biggest single-stock risk. You are paying, modestly, for a portfolio that has just underperformed the passive alternative you skipped.
Where CGGR Fits And Where It Doesn’t
CGGR is a credible active-growth vehicle at a near-index price, and its multi-year record holds up against the passive field. The case for buying it right now, on the strength of the same megacap names anyone can own through cheaper index products, is thinner.
The trailing-year cost has investors paying for real growth relative to passive ETFs that own the same top-five stocks with less discretion. Reserve CGGR for a satellite growth sleeve if you specifically want Capital Group’s research process on your side. If your only reason for owning it is Magnificent Seven exposure, the passive versions did the job better, cheaper, and more predictably.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks